Tavros Therapeutics

Tavros Therapeutics

Signal active

Organization

Contact Information

Overview

Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.

The company was founded in 2019 and based in Durham, North Carolina.

About

Industries

Biotechnology, Health Care, Wellness, Therapeutics

Founded

2019

Employees

1-10

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Tavros Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Wellness, Therapeutics sector. The company focuses on Biotechnology and has secured $1.3B in funding across 48 round(s). With a team of 1-10 employees, Tavros Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Corporate Round - Tavros Therapeutics, raised $17.5M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Eoin McDonnell

Eoin McDonnell

Co-founder and CEO

Funding Rounds

Funding rounds

3

Investors

1

Lead Investors

0

Total Funding Amount

$28.0M

Details

2

Tavros Therapeutics has raised a total of $28.0M in funding over 2 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2020Seed3.0M
2022Seed7.5M

Investors

Tavros Therapeutics is funded by 10 investors.

Investor NameLead InvestorFunding RoundPartners
Tavros Therapeutics-FUNDING ROUND - Tavros Therapeutics7.5M
KdT Ventures-FUNDING ROUND - KdT Ventures7.5M
Tavros Therapeutics-FUNDING ROUND - Tavros Therapeutics17.5M
Vividion Therapeutics-FUNDING ROUND - Vividion Therapeutics17.5M

Recent Activity

There is no recent news or activity for this profile.